4-Hydroxyphenylretinamide ≥97% (by TLC)

Supplier: Enzo Life Sciences
Danger

Synonyms: (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamideFenretinide4-HPRall-trans-N-(4-Hydroxyphenyl)retinamideN-(4-Hydroxyphenyl)-all- trans retinamideRetinoic Acid p-Hydroxyanilide

BML-GR103-0005
89158-744EA 150.09 USD
89158-744
4-Hydroxyphenylretinamide ≥97% (by TLC)
4-Hydroxyphenylretinamide

Retinoic acid receptor ligand.


An analog of all trans retinoic acid that shows antiproliferative activity on cultured human breast cancer cells. Highly selective activator of retinoid receptors. Induces apoptosis in malignant hemopoietic cell lines.


Soluble in DMSO (25 mg/mL) or 100% ethanol (25 mg/mL).

Formula: C₂₆H₃₃NO₂
MW: 391.56 g/mol
MDL Number: MFCD00792674
CAS Number: 65646-68-6
https://us.vwr.com/stibo/web/std.lang.all/39/03/45403903.jpg

Order Now

Specification Test Results

Source Synthetic
Purity ≥97% (TLC)
Appearance Orange solid

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR